Published in Blood Weekly, April 10th, 2008
"Here, we demonstrate that relative to normal myeloid stem/progenitor cells, RAR alpha 2 expression is dramatically reduced in primary AML blasts. Expression of the RAR alpha 1 isoform is also significantly reduced in primary AML cells, but not in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-04-10)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.